Current with changes from the 2024 Legislative Session
Section 12-6C-03.2 - Inspection of sterile drug products; report(a) Notwithstanding any other provision of this subtitle, a wholesale distributor applicant or permit holder that prepares sterile drug products shall submit to the Board a report of an inspection conducted by the U.S. Food and Drug Administration or a Board designee: (1) At the time of application; and(b) The inspection report required under subsection (a) of this section shall: (1) Be conducted within 1 year before the date of application or renewal; and(2) Demonstrate compliance with applicable federal good manufacturing practice standards.(c) An applicant or permit holder is responsible for obtaining an inspection to meet the requirements of this section.Md. Code, HO § 12-6C-03.2
Amended by 2015 Md. Laws, Ch. 5,Sec. 3, eff. 4/14/2015.Amended by 2014 Md. Laws, Ch. 45,Sec. 1, eff. 4/8/2014.Added by 2013 Md. Laws, Ch. 397,Sec. 1, eff. 7/1/2013.